New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Mettler-Toledo International Inc.
MTD
Shape
US Flag

NYSE

28B

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

28B

Medical - Diagnostics & Research

Next Earning date - 07 Nov 2024

1292.77USD
Shape-0.61 ( -0.05%)
favorite-chart

Relative Strenght

73
favorite-chart

Volume Buzz

-16%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated October 27, 2024
1W -5.34 % 1M -13.80 % 3M -10.97 % 1Y 34.33 %

Key Metrics

Shape
  • Market Cap

    27.61B


  • Shares Outstanding

    21.36M


  • Share in Float

    21.03M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    1292.77


  • Average Volume

    108218


  • Beta

    1.14


  • Range

    928.5-1546.93


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.mt.com


  • Sector

    Healthcare


Fundamentals

Shape

34.25x

P/E Ratio

7.36x

P/S Ratio

-180.08x

P/B Ratio

-13.5

Debt/Equity

21.0%

Net Margin

$36.3

EPS

How MTD compares to sector?

P/E Ratio

Relative Strength

Shape

MTD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape320%

2025-Revenue

$43.02

Shape313%

2025-EPS

$1B

Shape298%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Overweight

2024-08-27

Now: Equal-Weight

Jefferies

downgrade

Previous: Not converted

2024-06-03

Now: Underperform

J.P. Morgan

upgrade

Previous: Not converted

2022-12-20

Now: Neutral

Goldman Sachs

upgrade

Previous: Not converted

2022-11-08

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+17%

10.18
vs 8.72

Q4.22

arrow
arrow

+15%

12.1
vs 10.53

Q1.23

arrow
arrow

+10%

8.69
vs 7.87

Q2.23

arrow
arrow

+9%

10.19
vs 9.39

Q3.23

arrow
arrow

-4%

9.8
vs 10.18

Q4.23

arrow
arrow

-22%

9.4
vs 12.1

Q1.24

arrow
arrow

+2%

8.89
vs 8.69

Q2.24

arrow
arrow

-5%

9.65
vs 10.19

Q3.24

arrow
arrow

+2%

10.02
vs 9.8

Q4.24

arrow
arrow

+26%

11.88
vs 9.4

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

985.8M  vs 952M

Q4.22

arrow
arrow

+2%

1.1B  vs 1B

Q1.23

arrow
arrow

+3%

928.7M  vs 897.8M

Q2.23

arrow
arrow

+0%

982.1M  vs 978.4M

Q3.23

arrow
arrow

-4%

942.5M  vs 985.8M

Q4.23

arrow
arrow

-12%

935M  vs 1.1B

Q1.24

arrow
arrow

0%

925.9M  vs 928.7M

Q2.24

arrow
arrow

-4%

946.8M  vs 982.1M

Q3.24

arrow
arrow

+0%

944.8M  vs 942.5M

Q4.24

arrow
arrow

+8%

1B  vs 935M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-266%

-2.66
vs 29.2

Q4.22

arrow
arrow

+1072%

10.72
vs -2.66

Q1.23

arrow
arrow

-770%

-7.70
vs 10.72

Q2.23

arrow
arrow

-238%

-2.38
vs -7.70

Q3.23

arrow
arrow

-190%

-1.90
vs -2.38

Q4.23

arrow
arrow

-123%

-1.23
vs -1.90

Q1.24

arrow
arrow

-112%

-1.12
vs -1.23

Q2.24

arrow
arrow

-145%

-1.45
vs -1.12

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

712

712
vs 734

-3%

Q4.22

arrow
arrow

738

738
vs 712

4%

Q1.23

arrow
arrow

777

777
vs 738

5%

Q2.23

arrow
arrow

761

761
vs 777

-2%

Q3.23

arrow
arrow

736

736
vs 761

-3%

Q4.23

arrow
arrow

760

760
vs 736

3%

Q1.24

arrow
arrow

777

777
vs 760

2%

Q2.24

arrow
arrow

780

780
vs 777

0%

Earnings Growth

Latest News